mhurhangee/ep-ind-claims huggingface dataset:
Method for ascertaining an installation angle (α Install) between a roadway on which a vehicle travels and a detection direction of a measurement or radar sensor, wherein the method comprises the following steps: - reading a plurality of reflection signals which each represent a reflection signal which has been reflected from a measurement or radar beam emitted by a transmitting unit of the measurement or radar sensor and has been reflected on a different reflection portion of the vehicle, wherein the reflection signals contain movement information regarding a movement direction of the reflection portion of the vehicle on which the measurement or radar beam has been reflected, wherein the reflection signals contain position information which represents the position of the reflection portion of the vehicle on which the measuring or radar beam has been reflected; - detecting a movement direction component (v 0) of the movement directions of the reflection portions of the vehicle represented by the movement information from the plurality of reflection signals, wherein the measured radial velocities are different due to the different viewing angles of the reflection portions and, assuming that all reflection portions of the vehicle move forward at the same velocity and in the same direction, a common movement direction is ascertained therefrom as the movement direction component; and - determining the installation angle (α Install) using the detected movement direction component (v 0). - reading a plurality of reflection signals which each represent a reflection signal which has been reflected from a measurement or radar beam emitted by a transmitting unit of the measurement or radar sensor and has been reflected on a different reflection portion of the vehicle, wherein the reflection signals contain movement information regarding a movement direction of the reflection portion of the vehicle on which the measurement or radar beam has been reflected, wherein the reflection signals contain position information which represents the position of the reflection portion of the vehicle on which the measuring or radar beam has been reflected; - detecting a movement direction component (v 0) of the movement directions of the reflection portions of the vehicle represented by the movement information from the plurality of reflection signals, wherein the measured radial velocities are different due to the different viewing angles of the reflection portions and, assuming that all reflection portions of the vehicle move forward at the same velocity and in the same direction, a common movement direction is ascertained therefrom as the movement direction component; and - determining the installation angle (α Install) using the detected movement direction component (v 0).
A sintered cemented carbide, comprising 3 to 15 wt% of a binder comprising cobalt and optionally at least one of iron and nickel, from 1.0% to less than 4 wt% of a cubic carbonitride comprising Ti and optionally at least one of the elements Zr and Hf, wherein the cubic carbonitride is not less than 0.17 times the Co-content in wt% and is present in an amount sufficient to inhibit the accumulation of the binder on a surface of the sintered cemented carbide, and the nitrogen content as a mole ratio to Ti is greater than 0.05 and less than 0.6, the remainder tungsten carbide having an average grain size of 1.5μm or less, and wherein the percentage of the binder at the surface of the sintered cemented carbide is no greater than the bulk phase of said carbide.
Sound absorbing liner for the engine bay of a vehicle comprising at least one fibrous layer consisting of fibers and a binder thermally moulded to form the liner wherein the fibers comprise thermoplastic side by side bicomponent fibers and wherein the sides differ such that the fiber has a frizzy or curved shape characterised in that the binder is a thermoset binder.
Assembly comprising a graft vessel and an anastomosis connector; wherein the graft vessel is separated from a human or animal body; wherein the connector comprises a ring and two pins (17, 18); each pin (17, 18) having a free end and a fixed end connected to the ring; the pins (17, 18) extending, viewed from the fixed end towards the free end, next to and set apart from each other; each pin (17, 18) having an overlap section where the pin, viewed in axial direction of the ring, overlaps the plane bounded by the outer contour of the ring; wherein the connector is attached to the graft vessel; wherein the pins (17, 18) are arranged outside the graft vessel; and wherein the ring lies, with its full circumference, against the wall of the graft vessel; characterized, in that the axial axis of the ring extends transverse to the wall of the graft vessel.
A retraction or pull-out device for moving a movable furniture part or for moving a rail (6, 7) of a drawer pull-out guide relative to a furniture carcass, including an entrainment member which can be acted or which is acted upon by a force storage accumulator for acting a force onto the movable furniture part or onto the rail (6, 7) of the drawer pull-out guide, wherein the entrainment member has a pulling lever by way of which the movable furniture part or the rail (6, 7) of the drawer pull-out guide can be pulled into the opened or into the closed end position relative to the furniture carcass, wherein the pulling lever can be releasably coupled to the movable furniture part or to the rail (6, 7) of the drawer pull-out guide, characterized in that the pulling lever, for releasably coupling the pulling lever to the movable furniture part or to the rail (6, 7) of the drawer pull-out guide, either has at least two coupling locations (16a, 16b) or a coupling location which is movable between two positions, wherein either the at least two coupling locations (16a, 16b) or the two positions, between which the movable coupling location can be moved, are spaced from each other along the length of the pulling lever.
Gram-negative bacterial cells or Outer Membrane Vesicles (OMVs) derived therefrom which display on their outer surface an autotransporter fusion protein covalently coupled via an isopeptide bond to a heterologous molecule selected from the group of antigens, heterologous recombinant proteins, and therapeutic agents, wherein the AT fusion protein is an autotransporter protein that comprises at least one moiety of a Catcher/Tag ligation pair, and the heterologous molecule comprises the corresponding binding moiety of said Catcher/Tag ligation pair.
An attenuated clonal, viral replication inhibitory strain of Infectious Bursal Disease Virus (IBDV) comprising the RNA nucleotide sequence of the complete virus designated IBDV V903/78 as depicted in SEQ. ID. NO: 1 and 2, which can be grown in the HepG2 human liver cell line without causing detrimental effects to the cells.
A ventilation apparatus, in particular for air conditioning machines involving the passage of air from a low-pressure zone to a high-pressure zone, comprising a quadrangular support structure, which delimits one or more ventilation chambers, and a fan (8; 8c, 8s, 8d) for each ventilation chamber;the apparatus comprising one or more partitions (11; 25), each mounted inside the ventilation chamber so as to radially deflect the flow of air flowing out of the fan (8; 8c, 8s, 8d) in correspondence of a respective corner of the ventilation chamber itself; the apparatus comprising wings (14; 14I; 14II) having a wall that is tangent to the direction of the absolute speed of the flow of air flowing out of the fan (8; 8c, 8s, 8d); said wings having an inner wall and an outer wall at an angle relative to one another; the apparatus (5; 105) being characterized in that it comprises a plurality of double and single wings (14; 14I; 14II) arranged in correspondence of respective openings (O1, O2, O3, O4) of the support structure; wherein the double wings have an inner wall, an outer wall and a connector between the inner wall and the outer wall; wherein the inner wall is tangent to the direction of the absolute speed (v) of the flow of air flowing out of the fan (8; 8c, 8s, 8d); wherein the outer wall is inclined relative to said inner wall as a function of the direction to be given to the flow of air flowing out of the respective ventilation chamber.
A method of manufacturing ring segments for a segmented rolling bearing ring having at least one hardened rolling bearing raceway, the method comprising the following steps: a) manufacturing of ring segments from rolling bearing steel with a radius of curvature (r) and at least one unhardened raceway section in each case, b) inductive surface hardening of at least the unhardened raceway sections to produce hardened raceway sections, and d) machining of the ring segments to specified final dimensions, characterized in that between steps b) and d) the method comprises the following step: c) straightening the ring segments to adapt the radius of curvature (r) to a nominal radius of the segmented rolling bearing ring, the straightening comprising thermal straightening in which local structural changes are introduced into the ring segments by local heat input to adapt the radius of curvature (r). a) manufacturing of ring segments from rolling bearing steel with a radius of curvature (r) and at least one unhardened raceway section in each case, b) inductive surface hardening of at least the unhardened raceway sections to produce hardened raceway sections, and d) machining of the ring segments to specified final dimensions,
A fusion protein comprising at least two VHHs, comprising a single heavy chain variable domain antibody which binds to a biomaterial, selected from the group consisting of hydroxyapatite, calciumphosphate or a biocompatible metal coated with hydroxyapatite or calciumphosphate, and further comprising at least one VHH which binds to a BMP growth factor, which fusion protein is for use in a method of treatment for the regeneration, reconstruction and replacement of lost and worn out tissues.
A method comprising: (a) obtaining, by a computer system, sequencing data derived from a plurality of cell-free nucleic acid molecules that is obtained or derived from a subject; (b) processing, by implementing a code comprised in the the computer system, the sequencing data to identify one or more cell-free nucleic acid molecules of the plurality of cell-free nucleic acid molecules, wherein each of the one or more cell-free nucleic acid molecules comprises a plurality of phased variants relative to a reference genomic sequence, wherein at least about 10% of the one or more cell-free nucleic acid molecules comprises a first phased variant of the plurality of phased variants and a second phased variant of the plurality of phased variants that are separated by at least one nucleotide and wherein the first phased variant of the plurality of phased variants and the second phased variant of the plurality of phased variants are within 170 base pairs of each other; and (c) analyzing, by implementing a code comprised in the computer system, the identified one or more cell-free nucleic acid molecules to determine a condition of the subject, wherein the condition comprises a cancer which is not a hematological malignancy. (a) obtaining, by a computer system, sequencing data derived from a plurality of cell-free nucleic acid molecules that is obtained or derived from a subject; (b) processing, by implementing a code comprised in the the computer system, the sequencing data to identify one or more cell-free nucleic acid molecules of the plurality of cell-free nucleic acid molecules, wherein each of the one or more cell-free nucleic acid molecules comprises a plurality of phased variants relative to a reference genomic sequence, wherein at least about 10% of the one or more cell-free nucleic acid molecules comprises a first phased variant of the plurality of phased variants and a second phased variant of the plurality of phased variants that are separated by at least one nucleotide and wherein the first phased variant of the plurality of phased variants and the second phased variant of the plurality of phased variants are within 170 base pairs of each other; and (c) analyzing, by implementing a code comprised in the computer system, the identified one or more cell-free nucleic acid molecules to determine a condition of the subject, wherein the condition comprises a cancer which is not a hematological malignancy.
A luminous mesh comprising at least one wire mesh and luminous elements, the wire mesh comprising weft and warp wires, the luminous elements being provided on the wire mesh in rows and columns and arranged such that the luminous elements can be attached to a prefabricated wire mesh wherein at least two of the luminous elements are fastened to a support and fastened to the wire mesh together with the support, wherein at least the majority of the luminous elements can be controlled individually to output visual image sequences on the wire mesh, characterized in that the support comprises a rail.
A gene expression analysis method, comprising: a step of hybridizing a test nucleic acid to serve as a target to a nucleic acid probe in a support in which the nucleic acid probe having a test nucleic acid capture sequence at its 3' terminal side, a molecule recognition tag sequence, and a cell recognition tag sequence which has a known sequence and differs depending on the difference in position on the surface of the support is two-dimensionally distributed and immobilized on the surface of the support; a step of synthesizing a complementary DNA strand to the test nucleic acid, thereby preparing a cDNA library constituted by the DNA complementary strand containing the molecule recognition tag sequence and the cell recognition tag sequence; and a step of performing nucleic acid amplification of the whole or part of the cDNA library and correcting any amplification bias by utilizing the molecule recognition tag sequence. a step of hybridizing a test nucleic acid to serve as a target to a nucleic acid probe in a support in which the nucleic acid probe having a test nucleic acid capture sequence at its 3' terminal side, a molecule recognition tag sequence, and a cell recognition tag sequence which has a known sequence and differs depending on the difference in position on the surface of the support is two-dimensionally distributed and immobilized on the surface of the support; a step of synthesizing a complementary DNA strand to the test nucleic acid, thereby preparing a cDNA library constituted by the DNA complementary strand containing the molecule recognition tag sequence and the cell recognition tag sequence; and a step of performing nucleic acid amplification of the whole or part of the cDNA library and correcting any amplification bias by utilizing the molecule recognition tag sequence.
A specimen collection device comprising: a test block comprising a locking receiver void; a collector holder tube for insertion into the locking receiver void of the test block; and a specimen collector for insertion within the collector holder tube, the specimen collector comprising: a closure having an insert portion and a cap portion; an O-ring positioned on the insert portion such that the closure is biased towards a non- pivoted alignment when inserted within the collector holder tube; a shaft having a first end coupled to the insert portion and extending therefrom, the shaft terminating at a second end that has a collection swab coupled thereto; a chamber within the closure configured to hold a radio frequency identification tag therein, wherein the radio frequency identification tag is inserted into the chamber, and at least one locking flange extending from the cap portion and configured to engage a locking receiver of the test block; and a lid configured to sealingly engage the cap portion adjacent the chamber, wherein the seal between the lid and the cap portion is permanent. a test block comprising a locking receiver void; a collector holder tube for insertion into the locking receiver void of the test block; and a specimen collector for insertion within the collector holder tube, the specimen collector comprising: a closure having an insert portion and a cap portion; an O-ring positioned on the insert portion such that the closure is biased towards a non- pivoted alignment when inserted within the collector holder tube; a shaft having a first end coupled to the insert portion and extending therefrom, the shaft terminating at a second end that has a collection swab coupled thereto; a chamber within the closure configured to hold a radio frequency identification tag therein, wherein the radio frequency identification tag is inserted into the chamber, and at least one locking flange extending from the cap portion and configured to engage a locking receiver of the test block; and a lid configured to sealingly engage the cap portion adjacent the chamber, wherein the seal between the lid and the cap portion is permanent. a closure having an insert portion and a cap portion; an O-ring positioned on the insert portion such that the closure is biased towards a non- pivoted alignment when inserted within the collector holder tube; a shaft having a first end coupled to the insert portion and extending therefrom, the shaft terminating at a second end that has a collection swab coupled thereto; a chamber within the closure configured to hold a radio frequency identification tag therein, wherein the radio frequency identification tag is inserted into the chamber, and at least one locking flange extending from the cap portion and configured to engage a locking receiver of the test block; and a lid configured to sealingly engage the cap portion adjacent the chamber, wherein the seal between the lid and the cap portion is permanent.
A quantum cryptographic key distribution system comprising: - an optical source configured to generate a plurality of optical pulses; - a first optical beam splitter having a first, a second, a third and a fourth port and configured to generate, starting from each optical pulse, a first and a second optical sub-pulse, respectively on the third and fourth ports; - a first and a second peripheral device (50, 52); and - an optical path (50,52,82,84,90,92) having a first and a second end which are respectively connected to the third and fourth ports of the first optical beam splitter, said optical path extending through the first and second peripheral devices and also being configured to be traversed in a first and a second direction, respectively by the first and second optical sub-pulses, said first and second directions being opposite to one another, so that the first and second optical sub-pulses respectively impinge on the fourth and third ports of the first optical beam splitter; wherein the first peripheral device is configured to randomly phase shift the second optical sub-pulse by a first phase (φ A), and the second peripheral device is configured to randomly phase shift the first optical sub-pulse by a second phase (φ B); and wherein, in use, the first and second optical sub-pulses impinge concurrently on the first optical beam splitter, thereby causing interference in the first optical beam splitter between the first and second optical sub-pulses, said interference generating an optical signal in a deterministic manner on the first or the second port of the first optical beam splitter, or in an non-deterministic manner, as a function of a relation between the first and second phases; and wherein each of the first and second peripheral devices is configured to generate a cryptographic key on the basis of whether said optical signal, when generated in a deterministic manner, is generated on the first or the second port of the first optical beam splitter. - an optical source configured to generate a plurality of optical pulses; - a first optical beam splitter having a first, a second, a third and a fourth port and configured to generate, starting from each optical pulse, a first and a second optical sub-pulse, respectively on the third and fourth ports; - a first and a second peripheral device (50, 52); and - an optical path (50,52,82,84,90,92) having a first and a second end which are respectively connected to the third and fourth ports of the first optical beam splitter, said optical path extending through the first and second peripheral devices and also being configured to be traversed in a first and a second direction, respectively by the first and second optical sub-pulses, said first and second directions being opposite to one another, so that the first and second optical sub-pulses respectively impinge on the fourth and third ports of the first optical beam splitter;
A process for preparing the crystalline form A of febuxostat, (2-[3-cyano-4-(2-i-butoxy)phenyl]-4-methyl-5-thiazole carboxylic acid) comprising the following steps: a) Dissolving febuxostat in a solvent selected from the group consisting of ethyl acetate, isopropyl acetate and ethyl formiate in a proportion from 5 to 60 ml of solvent per gram of solute, at a temperature between 50°C and boiling temperature of the solution; b) Forming the crystals by keeping the solution from step a) at a temperature between 45°C and boiling temperature of the mixture over a period of 1-24 hours, when the solvent is ethyl acetate or isopropyl acetate; and c) Isolating the crystalline form A of febuxostat, by cooling at room temperature, from c.1.) the suspension from step b), and thereby standing over a period of 3-15 hours; or c.2.) the solution from step a), without going through step b), by stirring over a period of 3-24 hours, when the solvent is ethyl formiate; followed by filtration and drying. a) Dissolving febuxostat in a solvent selected from the group consisting of ethyl acetate, isopropyl acetate and ethyl formiate in a proportion from 5 to 60 ml of solvent per gram of solute, at a temperature between 50°C and boiling temperature of the solution; b) Forming the crystals by keeping the solution from step a) at a temperature between 45°C and boiling temperature of the mixture over a period of 1-24 hours, when the solvent is ethyl acetate or isopropyl acetate; and c) Isolating the crystalline form A of febuxostat, by cooling at room temperature, from c.1.) the suspension from step b), and thereby standing over a period of 3-15 hours; or c.2.) the solution from step a), without going through step b), by stirring over a period of 3-24 hours, when the solvent is ethyl formiate; c.1.) the suspension from step b), and thereby standing over a period of 3-15 hours; or c.2.) the solution from step a), without going through step b), by stirring over a period of 3-24 hours, when the solvent is ethyl formiate;
A neuropharmaceutical selected from the group consisting of a serotonergic drug, a dopaminergic drug, a noradrenergic drug, a GABAergic drug, and glycinergic drug for use in a method of neurological treatment by inducing voluntary locomotor activity in a mammal with a motor complete spinal cord injury or a brain injury, said method comprising applying transcutaneous electrical spinal cord stimulation (tSCS) to said mammal, wherein said transcutaneous electrical spinal cord stimulation is applied paraspinally over T11-T12 vertebrae, and comprises a stimulation signal ranging from 3 Hz to 100 Hz, wherein said stimulation signal is filled with a high frequency carrier signal that reduces sensitivity of pain receptors in said mammal and said transcutaneous electrical spinal cord stimulation is effective to facilitate voluntary movements of said mammal, wherein said stimulation is at an intensity that with said high frequency carrier signal does not induce discomfort and/or pain in said subject.